PRME vs SNY
Prime Medicine, Inc. Common Stock (PRME) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
SNY (SNY) common stock.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
SNY does not have a complete income-statement cache yet.
PRME currently screens at market cap $570.8M. SNY currently screens at market cap $0.
Not investment advice. Open the PRME and SNY stock pages for the full models.
Not investment advice.